These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30504328)

  • 1. Hypereosinophilic syndrome: approach to treatment in the era of precision medicine.
    Klion A
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):326-331. PubMed ID: 30504328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of the hypereosinophilic syndromes.
    Cogan E; Roufosse F
    Expert Rev Hematol; 2012 Jun; 5(3):275-89; quiz 290. PubMed ID: 22780208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic Agents for the Treatment of Hypereosinophilic Syndromes.
    Kuang FL; Klion AD
    J Allergy Clin Immunol Pract; 2017; 5(6):1502-1509. PubMed ID: 29122152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Hypereosinophilic Syndromes in Childhood].
    Leu T; Simon HU; Hebestreit H; Kunzmann S
    Klin Padiatr; 2015 Nov; 227(6-7):308-13. PubMed ID: 26267413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypereosinophilic syndrome and eosinophilic dermatitis with reslizumab.
    Kuruvilla M
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):670-671. PubMed ID: 29496465
    [No Abstract]   [Full Text] [Related]  

  • 6. How I treat hypereosinophilic syndromes.
    Klion AD
    Blood; 2015 Aug; 126(9):1069-77. PubMed ID: 25964669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I treat hypereosinophilic syndromes.
    Klion AD
    Blood; 2009 Oct; 114(18):3736-41. PubMed ID: 19692700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis.
    Williams AK; Dou C; Chen LYC
    Br J Haematol; 2021 Dec; 195(5):669-680. PubMed ID: 34105142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypereosinophilic syndrome: current approach to diagnosis and treatment.
    Klion A
    Annu Rev Med; 2009; 60():293-306. PubMed ID: 19630574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic management in patients with hypereosinophilic syndromes.
    Helbig G; Kyrcz-Krzemień S
    Pol Arch Med Wewn; 2011; 121(1-2):44-52. PubMed ID: 21346698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypereosinophilic Syndrome Subtype Predicts Responsiveness to Glucocorticoids.
    Khoury P; Abiodun AO; Holland-Thomas N; Fay MP; Klion AD
    J Allergy Clin Immunol Pract; 2018; 6(1):190-195. PubMed ID: 28757367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypereosinophilic syndrome: an update.
    Wilkins HJ; Crane MM; Copeland K; Williams WV
    Am J Hematol; 2005 Oct; 80(2):148-57. PubMed ID: 16184589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypereosinophilic syndromes].
    Groh M; Lefèvre G; Ackermann F; Étienne N; Kahn JE
    Rev Prat; 2019 Sep; 69(7):767-773. PubMed ID: 32233322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypereosinophilic syndromes in the precision medicine era: clinical, molecular aspects and therapeutic approaches (targeted therapies).
    Iurlo A; Cattaneo D; Gianelli U
    Expert Rev Hematol; 2019 Dec; 12(12):1077-1088. PubMed ID: 31588817
    [No Abstract]   [Full Text] [Related]  

  • 15. L6. Eosinophilic granulomatosis with polyangiitis: future therapies.
    Moosig F
    Presse Med; 2013 Apr; 42(4 Pt 2):510-2. PubMed ID: 23453508
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome.
    Kuang FL; Fay MP; Ware J; Wetzler L; Holland-Thomas N; Brown T; Ortega H; Steinfeld J; Khoury P; Klion AD
    J Allergy Clin Immunol Pract; 2018; 6(5):1518-1527.e5. PubMed ID: 29751154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapies for hypereosinophilic syndromes.
    Antoniu SA
    Neth J Med; 2010 Aug; 68(1):304-10. PubMed ID: 20739727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review.
    Yoon TY; Ahn GB; Chang SH
    J Dermatol; 2000 Feb; 27(2):110-5. PubMed ID: 10721659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes.
    Dispenza MC; Bochner BS
    Curr Hematol Malig Rep; 2018 Jun; 13(3):191-201. PubMed ID: 29680938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.
    Schwartz LB; Sheikh J; Singh A
    Curr Med Res Opin; 2010 Aug; 26(8):1933-46. PubMed ID: 20565230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.